Status:
RECRUITING
Effect of Transcranial Magnetic Stimulation on Visual Functions of Adult Amblyopia: a Preliminary Study
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Amblyopia
Eligibility:
All Genders
20-50 years
Phase:
NA
Brief Summary
Amblyopia, with a prevalence rates of 3% in adult population, is a common cause of vision impairment. It is characterized by impaired vision in one or both eyes because of disruption of normal visual ...
Eligibility Criteria
Inclusion
- Adult amblyopia participants, aged 20-50 years old.
- Based on inclusion criteria, there was a minimum of 2 lines difference in BCVA between the 2 eyes.
- An amblyogenic factor and history of amblyopia treatment was recorded
Exclusion
- Unstable vital sign
- History of brain injury and/or head trauma
- Neurological and psychiatric disease
- Seizures or family history of seizure
- Pregnancy
- Uncontrolled migraine or the presence of metallic implants or shunt in the head or torso
- Wide region of ischemic cicatrix, multiple sclerosis, taking tricycle antidepressants,
- Analgesics or any drugs may decrease the threshold for inducing seizure
- Experienced sleep disorders during the rTMS treatment
- Severe alcoholism or taking seizure drugs
- Severe heart diseases or uncontrollable migraine caused by high intracranial pressure
Key Trial Info
Start Date :
January 5 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05393739
Start Date
January 5 2023
End Date
December 31 2025
Last Update
June 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei County, Taiwan, 100225